<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7647782</article-id><article-id pub-id-type="doi">10.1155/2020/9835167</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Cytotoxic, Antioxidant, and Metabolic Enzyme Inhibitory Activities of <italic>Euphorbia cyparissias</italic> Extracts</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9430-7980</contrib-id><name><surname>Alonazi</surname><given-names>Mona</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6499-8007</contrib-id><name><surname>Horchani</surname><given-names>Habib</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3420-1164</contrib-id><name><surname>Alwhibi</surname><given-names>Mona</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6372-7483</contrib-id><name><surname>Ben Bacha</surname><given-names>Abir</given-names></name><email>aalghanouchi@ksu.edu.sa</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Biochemistry Department, Science College, King Saud University, Riyadh, Saudi Arabia</aff><aff id="I2">
<sup>2</sup>Science Department, College of Rivi&#x000e8;re-Du-Loup, Rivi&#x000e8;re-Du-Loup, Qu&#x000e9;bec, Canada G5R1E2</aff><aff id="I3">
<sup>3</sup>Botany and Microbiology Department, Science College, King Saud University, Riyadh, Saudi Arabia</aff><aff id="I4">
<sup>4</sup>Laboratory of Plant Biotechnology Applied to Crop Improvement, Faculty of Science of Sfax, University of Sfax, Tunisia</aff><author-notes><fn fn-type="other"><p>Academic Editor: Nicoletta Guaragnella</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>29</day><month>10</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>9835167</elocation-id><history><date date-type="received"><day>2</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>4</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Mona Alonazi et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Plants of the Euphorbia genus present a wide range of therapeutic applications. This study is aimed at investigating new antidigestive enzyme agents from <italic>Euphorbia cyparissias</italic> through inhibition of lipid and carbohydrate absorption, to evaluate their potential applications for the treatment of metabolic syndrome. Lipase, phospholipase, protease, <italic>&#x003b1;</italic>-amylase, <italic>&#x003b2;</italic>-glucosidase, and xanthine oxidase activities under treatment with aqueous and ethanolic extracts of <italic>Euphorbia cyparissias</italic> were observed to evaluate the inhibitory effect of these extracts, as well as their antioxidant and cytotoxic effects. Results showed that ethanolic and aqueous extracts exhibited important inhibitory activity in a concentration-related manner on digestive enzymes, which is more effective than the commercial drugs used as controls. Results also showed that, out of the two extracts tested, the ethanolic extract presented the most promising results in inhibiting the activities of all digestive enzymes used. Moreover, the two extracts displayed a higher reducing power than that of the positive control used. The obtained results, together with previous reports in the literature, strongly suggest that <italic>Euphorbia cyparissias</italic> extracts may be natural inhibitors of the digestive enzymes and thus a potential new drug for metabolic syndrome treatment.</p></abstract><funding-group><award-group><funding-source>Deanship of Scientific Research, King Saud University</funding-source><award-id>RG-1441-471</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Metabolic syndrome is a serious and escalating worldwide public health threat that directly increases the risk of developing obesity, diabetes, atherosclerosis, and hypertension, or combinations [<xref rid="B1" ref-type="bibr">1</xref>]. These metabolic abnormalities are related to, among other enzymes, lipolytic enzymes such as pancreatic lipases, phospholipases, and proteases and metabolic enzymes like <italic>&#x003b2;</italic>-glucosidase, <italic>&#x003b1;</italic>-amylase, and xanthine oxidase (XO) [<xref rid="B2" ref-type="bibr">2</xref>]. The prevalence of the metabolic syndrome is increasing to epidemic proportions not only in the United States and the remainder of the urbanized world but also in developing nations [<xref rid="B3" ref-type="bibr">3</xref>]. In most countries, between 20% and 30% of the adult population suffer from metabolic syndrome [<xref rid="B4" ref-type="bibr">4</xref>]. Because of this high prevalence and the consequences of metabolic syndrome, which is an important contributor to the increase in cardiovascular and diabetes risks worldwide, special therapeutic attention should be devoted.</p><p>The currently used approach is focused on weight reduction and physical activity. However, it has been reported that polyphenolic extracts from various plants may positively influence different features of metabolic syndrome and control hyperlipidemia in people with obesity, by directly influencing the activities of metabolic enzymes [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. Independent of their antioxidant activities, these extracts were found to be effective inhibitors of lipases [<xref rid="B7" ref-type="bibr">7</xref>], proteases [<xref rid="B8" ref-type="bibr">8</xref>], <italic>&#x003b2;</italic>-glucosidase [<xref rid="B9" ref-type="bibr">9</xref>], and <italic>&#x003b1;</italic>-amylase activities [<xref rid="B10" ref-type="bibr">10</xref>] and can also cause insulin-like effects in glucose utilization [<xref rid="B11" ref-type="bibr">11</xref>]. While multiple types of drugs have been developed to help ease the pain, they do not come without side effects. Indeed, anti-inflammatory drugs such as Naproxen, Celecoxib, and Indomethacin are harmful for the digestive system and can lead to stomach pain, diarrhea, nausea, and stomach ulcers [<xref rid="B12" ref-type="bibr">12</xref>]. Alternatively, plants and their products have been used as drugs for thousands of years, and the recently renewed interest in researching effective drugs with less adverse effects has provided a definitive stimulus for the development of natural product chemistry.</p><p>Some <italic>Euphorbia</italic> plants have been identified as having antioxidant effects, such as <italic>Euphorbia royleana Boiss</italic> [<xref rid="B13" ref-type="bibr">13</xref>], <italic>Euphorbia hirta</italic> L. [<xref rid="B14" ref-type="bibr">14</xref>], <italic>Euphorbia heterophylla</italic> Desf. [<xref rid="B15" ref-type="bibr">15</xref>], and <italic>Euphorbia cuneata</italic> Vahi [<xref rid="B16" ref-type="bibr">16</xref>]. Interestingly, the use of Euphorbia spp. L constituents as remedy for diseases, like antipyretic, analgesic, anxiolytic, and anti-inflammatory, has been previously stated in literatures [<xref rid="B14" ref-type="bibr">14</xref>] and thus can be used to inhibit secreted inflammatory enzymes such as secreted phospholipase A2 (PLA2) [<xref rid="B17" ref-type="bibr">17</xref>], among other phospholipases. According to several studies, digestive enzymes are implicated in metabolic syndrome components, namely, obesity, hypertension, hyperglycemia, hypertriglyceridemia, and hypercholesterolemia, and this metabolic imbalance is related specifically to lipolytic and metabolic enzymes such as pancreatic lipase, <italic>&#x003b2;</italic>-glucosidase, <italic>&#x003b1;</italic>-amylase, and XO [<xref rid="B8" ref-type="bibr">8</xref>]. Considering all these facts and in order to prevent metabolic syndrome, searching a natural drug without undesirable side effects should be an urgent purpose. Thus, the present study is aimed at investigating if <italic>Euphorbia cyparissias L</italic>. (<italic>E. cyparissias</italic>) possesses inhibitory effects on some important digestive enzymes in addition to its possible cytotoxicity on three human cell lines.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Plant Material and Extraction Procedure</title><p>Fresh leaves of <italic>E. cyparissias</italic> (KSU No. 19378) were collected from individuals of the Al-amariah region (North of Riyadh, Saudi Arabia; 24&#x000b0;48&#x02032;35.1<sup>&#x02033;</sup>N 46&#x000b0;25&#x02032;34.1<sup>&#x02033;</sup>E, in 2007), then were identified and confirmed by Dr. Mona S. Alwahibi. After washing in distilled water, the leaves were air-dried for 3 days at room temperature (25&#x000b0;C) until use. A portion of ground plant material (20&#x02009;g) was macerated and homogenized with 200&#x02009;mL of distilled water or 70% ethanol for 24&#x02009;h at ambient temperature. Thereafter, the homogenate was filtered through a Buchner funnel and centrifuged for 15&#x02009;min at 5.000&#x02009;rpm. The resulting supernatant was concentrated using rotary evaporator, then transferred into 100&#x02009;ml beaker and left for 4 days on laboratory bench to dry properly and stored at 4&#x000b0;C until use.</p></sec><sec id="sec2.2"><title>2.2. Enzymes</title><p>Dromedary (DrPlA<sub>2</sub>-IB), porcine (PPPlA<sub>2</sub>-IB), and stingray group IB phospholipases (SPLA<sub>2</sub>-IB) were purified and prepared as described in our previous works [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>] and De Haas et al. [<xref rid="B20" ref-type="bibr">20</xref>], respectively. Dromedary (DrPL), stingray (SPL), and porcine (PPL) lipases were also purified according to protocols optimized in previous works [<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>]. The enzymes <italic>&#x003b2;</italic>-glucosidase, <italic>&#x003b1;</italic>-amylase, and XO were purchased from Sigma-Aldrich (St. Louis, MO, USA).</p></sec><sec id="sec2.3"><title>2.3. Lipolytic Enzyme Activity Inhibition</title><p>The inhibitory effect of ethanolic and aqueous extracts of <italic>E. cyparissias</italic> on dromedary, stingray, and porcine lipase activities were investigated at different concentrations ranging from 0 to 100&#x02009;<italic>&#x003bc;</italic>g/mL. The assay was carried out by incubating 12&#x02009;IU of enzymes (50&#x02009;<italic>&#x003bc;</italic>L) with 10&#x02009;<italic>&#x003bc;</italic>L of extract. A positive control using commercial orlistat (Xenical, Hoffmann-La Roche) was run in parallel in the same conditions. Inhibition of lipase activities was expressed as the percentage of residual activity after incubation with Euphorbia extracts compared to the negative control (no enzyme added). Lipase activities were measured using tributyrin as a substrate under the optimal conditions for each enzyme, as previously described [<xref rid="B17" ref-type="bibr">17</xref>]. The IC<sub>50</sub> values correspond to the half maximal inhibitory concentration.</p></sec><sec id="sec2.4"><title>2.4. Phospholipase Activity Inhibition</title><p>The phospholipase activities were measured based on the De Ara&#x000fa;jo and Radvanyi method [<xref rid="B24" ref-type="bibr">24</xref>]. The inhibitory effect of various extracts was determined using samples of dromedary, stingray, and porcine digestive group IB phospholipases (PLA2-IB). A 10&#x02009;<italic>&#x003bc;</italic>L sample of ethanolic or aqueous extract was mixed with 10&#x02009;<italic>&#x003bc;</italic>L of PLA2-GIB and preincubated for 20&#x02009;min at room temperature. The mixture was added to 1&#x02009;mL of the substrate, which was composed of lecithin (3.5&#x02009;mM) solubilized in 100&#x02009;mM NaCl, 3&#x02009;mM sodium taurodeoxycholate, 10&#x02009;mM CaCl<sub>2</sub>, and 0.055&#x02009;mM red phenol at a pH of 7.6. The activity was verified by measuring spectrophotometrically the absorbance at 558&#x02009;nm for 5&#x02009;min. The inhibition percentage was calculated by measuring residual activity compared to negative control assay (absence of extract). The IC<sub>50</sub> values were determined from the curve.</p></sec><sec id="sec2.5"><title>2.5. <italic>&#x003b1;</italic>-Amylase and <italic>&#x003b2;</italic>-Glucosidase Activity Inhibition</title><p>Alpha amylase activity was measured according to Subranian et al. [<xref rid="B25" ref-type="bibr">25</xref>]. A 10&#x02009;<italic>&#x003bc;</italic>L sample of <italic>&#x003b1;</italic>-amylase (3&#x02009;IU) was mixed with a final concentration range from 0 to 500&#x02009;<italic>&#x003bc;</italic>g/mL of <italic>E. cyparissias</italic> aqueous and ethanolic extracts at 37&#x000b0;C for 5&#x02009;min. Acarbose was used as a positive control. The residual activity was evaluated by measuring twice the absorbance at 620&#x02009;nm after 8&#x02009;min (A1) and 13&#x02009;min (A2) after incubation with substrate (180&#x02009;<italic>&#x003bc;</italic>L of lab test diluted in water (<italic>v</italic>/<italic>v</italic>)). The reaction was carried out in a microplate (Bio-Tek ELX-800, Winooski, VT, USA). The <italic>&#x003b1;</italic>-amylase inhibition (<italic>i</italic>) was calculated as follows: <italic>i</italic>&#x02009;(%) = 100&#x02013;(A2&#x02013;A1/A2&#x02009;control&#x02013;A1&#x02009;control) &#x000d7; 100, where A1 is the absorbance of the initial reading and A2 is the absorbance of the second reading.</p><p>The <italic>&#x003b2;</italic>-glucosidase activity was determined by measuring the 4-nitrophenol <italic>&#x003b1;</italic>-D&#x02032;glucopyranoside (4-NPGP) product. A 180&#x02009;<italic>&#x003bc;</italic>L sample of <italic>&#x003b2;</italic>-glucosidase was preincubated for 2&#x02009;min at 37&#x000b0;C with 20&#x02009;<italic>&#x003bc;</italic>L of <italic>E. cyparissias</italic> aqueous and ethanolic extracts or with a positive control (Acarbose) at a concentration range of 0 to 100&#x02009;<italic>&#x003bc;</italic>g/mL. Then, the mixture was incubated with color reagent NPGP (180&#x02009;<italic>&#x003bc;</italic>L) for more 15&#x02009;min at 37&#x000b0;C. The colorimetric test contained 10&#x02009;mM of potassium phosphate buffer, 5&#x02009;mM of 4-NPGP, and 2&#x02009;IU of <italic>&#x003b2;</italic>-glucosidase, at pH&#x02009;6.9. The activity was evaluated by measuring absorbance at 405&#x02009;nm with a microplate reader. The same equation used to measure <italic>&#x003b1;</italic>-amylase activity was used to measure that of <italic>&#x003b2;</italic>-glucosidase.</p></sec><sec id="sec2.6"><title>2.6. XO Inhibitory Activity Inhibition</title><p>According to methodology described by Bondet et al. [<xref rid="B26" ref-type="bibr">26</xref>], XO activity was determined by measuring the formation of uric acid from xanthine at 295&#x02009;nm. The first reagent was a mixture of xanthine (667&#x02009;mM), EDTA (0.1&#x02009;mM), hydroxylamine (0.2&#x02009;mM), and phosphate buffer (50&#x02009;mM, pH&#x02009;7.5). In each microplate well, 15&#x02009;<italic>&#x003bc;</italic>L of <italic>E. cyparissias</italic> aqueous or ethanolic extract (0 to 100&#x02009;<italic>&#x003bc;</italic>g/mL) and 40&#x02009;<italic>&#x003bc;</italic>L of XO were preincubated for 5&#x02009;min at 37&#x000b0;C. After that, 95&#x02009;<italic>&#x003bc;</italic>L from the first reagent was added into each microplate well and incubated at 37&#x000b0;C for 30&#x02009;min. Then, 150&#x02009;<italic>&#x003bc;</italic>L of uric acid reagent was added in the mixture and the absorbance was measured again. Ethanol was used as a negative control and allopurinol as a positive control. The same equation used to measure <italic>&#x003b1;</italic>-amylase and <italic>&#x003b2;</italic>-glucosidase activities was used to measure that of XO.</p></sec><sec id="sec2.7"><title>2.7. Protease Activity Inhibition</title><p>The trypsin and chymotrypsin activity inhibition was performed as described by Kunitz [<xref rid="B27" ref-type="bibr">27</xref>]. An aliquot of 1&#x02009;mL of ethanolic or water extract was incubated for 15&#x02009;min at 37&#x000b0;C with an equal volume of the enzyme. The mixture was then incubated for 30&#x02009;min at 37&#x000b0;C with 2&#x02009;mL of 2% casein as the substrate. The reaction was stopped by adding 2.5&#x02009;mL of 5% trichloroacetic acid (TCA). The activity was determined by measuring the absorbance of the mixture at 280&#x02009;nm, after 15&#x02009;min of centrifugation at 15 000&#x02009;rpm. Ethanol was used as a negative control and Bowman-Birk Inhibitor (BBI) as a positive control. The protease activity inhibition was also expressed as inhibition percentage, which was determined by comparing the results with those of a control experiment.</p></sec><sec id="sec2.8"><title>2.8. Antioxidant Assays</title><p>In every sample of <italic>E. cyparissias</italic> extract, the antioxidant activity was evaluated by using the DPPH radical scavenging and reducing power assays as previously described in the literature [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>]. To measure DPPH activity, a sample of 0.5&#x02009;mL for each concentration was mixed with an equal volume of DPPH ethanolic solution and incubated in darkness for 1&#x02009;h at ambient temperature. The activity was determined by comparing the absorbance at 519&#x02009;nm of DPPH radicals to that of the control (containing all reagents except the extract).</p><p>To measure reducing power activity, extracts with concentrations ranging from 0.03 to 1&#x02009;mg/mL were mixed with 1&#x02009;mL of 1% potassium ferricyanide and 1&#x02009;mL of 0.2&#x02009;M sodium phosphate buffer (pH&#x02009;6.6). After incubation for 20&#x02009;min at 50&#x000b0;C, 1.25&#x02009;mL of 20% TCA was added to the mixture and was centrifuged for 10&#x02009;min at 3000&#x02009;rpm. Finally, the upper layer solution (1.25&#x02009;mL) was mixed with an equal volume of deionized water and 0.5&#x02009;mL of 0.1% fresh ferric chloride. The absorbance of the obtained mixture was measured at 700&#x02009;nm using distilled water as the blank and butylated hydroxytoluene (BHT) as a positive control.</p></sec><sec id="sec2.9"><title>2.9. Cytotoxicity Assays</title><p>In order to test the possible cytotoxic effect of the two extracts on human cell lines, the viability of human MDA-MB-231 breast cancer cells (ATTC, Manassas, VA, USA), Lovo, and HCT-116 cell lines were evaluated after incubation for 48&#x02009;h with different concentrations of ethanolic and aqueous extracts from <italic>E. cyparissias</italic>. Cells were grown to confluence at 37&#x000b0;C under 5% CO<sub>2</sub> in DMEM medium supplemented with 15% fetal bovine serum, 2&#x02009;mM L-glutamine, 1&#x02009;mg/mL D-glucose, 1% nonessential amino acids, 100&#x02009;IU/mL of penicillin, and 100&#x02009;<italic>&#x003bc;</italic>g/mL of streptomycin. Solutions containing 10, 25, 50, and 50&#x02009;<italic>&#x003bc;</italic>g/mL were mixed with DMEM. A negative control was run in parallel using the same volume of saline buffer. After 24&#x02009;h, MDA-MB-231, Lovo, and HCT-116 cells were fixed with 1% glutaraldehyde, stained with a solution of 0.1% crystal violet, and lysed with 1% sodium dodecyl sulfate (SDS). Absorbance was then measured at 600&#x02009;nm. Experiments were carried out in triplicate. Cytotoxicity was expressed as a relative percentage of the optical density (OD) values measured in the control and those of ethanolic and aqueous extract-treated cells.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Evaluation of <italic>E. cyparissias</italic> Extracts on Digestive Lipolytic Enzyme Inhibition</title><p>As shown in Figures <xref ref-type="fig" rid="fig1">1(a)</xref>&#x02013;<xref ref-type="fig" rid="fig1">1(c)</xref>, the two extracts as well as the commercial inhibitor tested caused a dose-dependent inhibition at the concentrations range used. One can also note that, out of the two extracts tested, the ethanolic extract showed the most promising results in inhibiting the lipolytic activity of the three enzymes with an IC<sub>50</sub> of 8.0 &#x000b1; 0.4&#x02009;<italic>&#x003bc;</italic>g/mL, 2.9 &#x000b1; 0.4&#x02009;<italic>&#x003bc;</italic>g/mL, and 2.3 &#x000b1; 0.3&#x02009;<italic>&#x003bc;</italic>g/mL for DrPL, SPL, and PPL, respectively (<xref rid="tab1" ref-type="table">Table 1</xref>). The aqueous extract inhibited the three enzymes with an IC<sub>50</sub> of 23.1 &#x000b1; 0.4&#x02009;<italic>&#x003bc;</italic>g/mL for DrPL, 21.0 &#x000b1; 0.3&#x02009;<italic>&#x003bc;</italic>g/mL for SPL, and 27.2 &#x000b1; 0.3&#x02009;<italic>&#x003bc;</italic>g/mL for PPL. Notably, the inhibitory potency of the two extracts on tested lipase activities was more pronounced than that of the commercial drug orlistat showing IC<sub>50</sub> values of 97.2 &#x000b1; 2.5&#x02009;<italic>&#x003bc;</italic>g/L, 109.8 &#x000b1; 4.2&#x02009;<italic>&#x003bc;</italic>g/L, and 52.1 &#x000b1; 2.3&#x02009;<italic>&#x003bc;</italic>g/L for DrPL, SPL, and PPL, respectively.</p><p>
<xref ref-type="fig" rid="fig2">Figure 2</xref> shows the inhibitory effect of ethanolic and aqueous extracts from <italic>E. cyparissias</italic> on the three digestive phospholipases used. Interestingly, the obtained data clearly indicated that both the ethanolic and the aqueous extracts (Figures <xref ref-type="fig" rid="fig2">2(a)</xref> and <xref ref-type="fig" rid="fig2">2(b)</xref>) effectively suppressed activities of all phospholipases used better than the oleanolic acid used as a positive control (<xref ref-type="fig" rid="fig2">Figure 2(c)</xref>). The IC<sub>50</sub> values presented in <xref rid="tab2" ref-type="table">Table 2</xref> showed that the ethanolic extract was about two to three times more efficient to inhibit the digestive phospholipases used than the aqueous extract. The ethanolic extract inhibited the three enzymes with an IC<sub>50</sub> of 4.2 &#x000b1; 0.2&#x02009;<italic>&#x003bc;</italic>g/mL for DrPLA<sub>2</sub>-IB, 5.9 &#x000b1; 0.2&#x02009;<italic>&#x003bc;</italic>g/mL for SPLA<sub>2</sub>-IB, and 9.6 &#x000b1; 0.2&#x02009;<italic>&#x003bc;</italic>g/mL for PPLA<sub>2</sub>-IB.</p></sec><sec id="sec3.2"><title>3.2. Evaluation of <italic>&#x003b1;</italic>-Amylase, <italic>&#x003b2;</italic>-Glucosidase, XO, and Protease Activity Inhibition</title><p>As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, most of the enzymes tested including <italic>&#x003b1;</italic>-amylase, <italic>&#x003b2;</italic>-glucosidase, and XO were inhibited in a dose-dependent manner after incubation with ethanolic and aqueous extracts of <italic>E. cyparissias</italic> (Figures <xref ref-type="fig" rid="fig3">3(a)</xref>&#x02013;<xref ref-type="fig" rid="fig3">3(c)</xref>). The values of IC<sub>50</sub> presented in <xref rid="tab3" ref-type="table">Table 3</xref> allowed us to quantify more precisely the inhibitory effect of the two extracts on enzyme activities compared to those of the positive controls. Ethanolic extract presented the most promising results in inhibiting <italic>&#x003b1;</italic>-amylase, <italic>&#x003b2;</italic>-glucosidase, and XO, with IC<sub>50</sub> values of 98.8 &#x000b1; 8.6&#x02009;<italic>&#x003bc;</italic>g/mL, 8.1 &#x000b1; 0.3&#x02009;<italic>&#x003bc;</italic>g/mL, and 7.2 &#x000b1; 0.7&#x02009;<italic>&#x003bc;</italic>g/mL, respectively, followed by aqueous extract and positive controls.</p><p>Data presented in <xref ref-type="fig" rid="fig4">Figure 4</xref> demonstrated that the inhibition of trypsin (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>) and chymotrypsin (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>) by ethanolic or aqueous extracts is limited, and complete inhibition was not achieved at the concentrations used (0 to 100&#x02009;<italic>&#x003bc;</italic>g/mL) compared to positive control. This finding is supported by the IC<sub>50</sub> values presented in <xref rid="tab4" ref-type="table">Table 4</xref>. BBI had the higher inhibitory effect on trypsin activity with an IC<sub>50</sub> value of 11.5 &#x000b1; 0.4&#x02009;<italic>&#x003bc;</italic>g/mL, followed by ethanolic extract with an IC<sub>50</sub> of 84.1 &#x000b1; 2.1&#x02009;<italic>&#x003bc;</italic>g/mL and by aqueous extract with an IC<sub>50</sub> higher than 100&#x02009;<italic>&#x003bc;</italic>g/mL. The same result was obtained with chymotrypsin, which lost its IC<sub>50</sub> at a concentration of 10.8 &#x000b1; 0.4&#x02009;<italic>&#x003bc;</italic>g/mL compared to 77.5 &#x000b1; 1.1&#x02009;<italic>&#x003bc;</italic>g/mL for ethanolic extract and a value higher than 100&#x02009;<italic>&#x003bc;</italic>g/mL for aqueous extract.</p></sec><sec id="sec3.3"><title>3.3. Antioxidant Activity of Ethanolic and Aqueous Extracts of <italic>E. cyparissias</italic></title><p>The antiradical activities of different concentration of the two extracts were determined using DPPH free radical assay, and results were compared to those of the BHT, which was used as a positive control (<xref ref-type="fig" rid="fig5">Figure 5(a)</xref>). The activities of the two extracts were expressed as the mean of IC<sub>50</sub> (mg/mL) values (<xref ref-type="fig" rid="fig5">Figure 5(b)</xref>). The scavenging activities of the two extracts as well as of the BHT were concentration dependent. Results showed that, at a concentration of 1&#x02009;mg/mL, the ethanolic and aqueous extracts presented high scavenging activities, with values of 90.6 &#x000b1; 1.2% and 88.2 &#x000b1; 1.0%, respectively, which were close to that of BHT, with 95.3 &#x000b1; 0.4%. This finding was confirmed by the IC<sub>50</sub> values shown in <xref ref-type="fig" rid="fig5">Figure 5(b)</xref>, which presents an IC<sub>50</sub> of ~0.073&#x02009;mg/mL, ~0.22&#x02009;mg/mL, and~0.054&#x02009;mg/L for ethanolic extract, aqueous extract, and BHT, respectively.</p></sec><sec id="sec3.4"><title>3.4. Cytotoxicity of Ethanolic and Aqueous Extracts of <italic>E. cyparissias</italic></title><p>The cytotoxicity of <italic>E. cyparissias</italic> extracts in MDA-MB-231, Lovo, and HCT-116 cells was evaluated by measuring the cell density in the presence of increasing concentrations of extracts (0-100&#x02009;<italic>&#x003bc;</italic>g/mL) (Figures <xref ref-type="fig" rid="fig6">6(a)</xref> and <xref ref-type="fig" rid="fig6">6(b)</xref>). This concentration range is the same with that used in previous experiments aiming to test their inhibitory effect on digestive enzymes. Results showed that there is more cell death in the presence of the ethanolic extract than in the presence of the aqueous extract particularly at a concentration of 100&#x02009;<italic>&#x003bc;</italic>g/mL for the three type of cells used (<xref rid="tab5" ref-type="table">Table 5</xref>). However, at a lower concentration, between 10 and 25&#x02009;<italic>&#x003bc;</italic>g/mL, one can note that the three cell lines used are more resistant to the two extracts than with higher concentrations. No significant decrease in the cell number was observed in the presence of the two extracts at a concentration of 10&#x02009;<italic>&#x003bc;</italic>g/mL. An average of about 55% of the total cell number was viable and resistant in the presence of 25&#x02009;<italic>&#x003bc;</italic>g/mL of the ethanolic extract. In contrast, 100% of the cells were viable in the presence of the aqueous extract.</p><p>
<xref rid="tab6" ref-type="table">Table 6</xref> shows a comparison of IC<sub>50</sub> average values (<italic>&#x003bc;</italic>g/mL) calculated from individual IC<sub>50</sub> values for each enzyme families presented previously. As shown in this table, most of the mean values of IC<sub>50</sub> for ethanolic and aqueous extracts on all digestive enzymes used are lower than the lower cytotoxic concentration that caused 50% of cell death (30&#x02009;<italic>&#x003bc;</italic>g/mL for ethanolic extract and &#x0003e;100&#x02009;<italic>&#x003bc;</italic>g/mL for aqueous extract).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>According to the National Health and Nutrition Examination Surveys (NHANES, 2009-2010), approximately 69% of US adults are overweight or obese, with more than 78 million adult Americans considered obese (U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), and National Heart, Lung, and Blood Institute (NHLBI)) [<xref rid="B30" ref-type="bibr">30</xref>]. It is safe to assume that obesity is a public health problem. One of the most promising targets to regulate and prevent obesity is through the inhibition of the digestion and absorption of dietary fat [<xref rid="B31" ref-type="bibr">31</xref>]. Pancreatic lipases are the targeted enzymes because of their role in the dietary lipids' digestion. In this study, three digestive lipases, which are DrPL, SPL, and PPL, had their activities evaluated in the presence of different concentrations (0-100&#x02009;<italic>&#x003bc;</italic>g/mL) of aqueous and ethanolic extracts of <italic>E. cyparissias</italic> or orlistat, a potent inhibitor of gastric and pancreatic lipases and among the most used drugs in obesity, and possibly diabetes, treatment [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>]. It is noteworthy that the two extracts presented a stronger inhibition effect of activities of the three lipases tested than that of orlistat at all concentrations used (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Interestingly, <italic>E. cyparissias</italic> extracts and more specifically ethanolic extract (IC<sub>50</sub> of 2.3 &#x000b1; 0.3&#x02009;<italic>&#x003bc;</italic>g/mL) was found to be more effective in inhibiting the catalytic activity of PPL than previously reported plant extracts such as common plant sterols sitosterol and stigmasterol [<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B37" ref-type="bibr">37</xref>] and positive controls such as orlistat (IC<sub>50</sub> of 12.3 &#x000b1; 0.1&#x02009;<italic>&#x003bc;</italic>g/mL) [<xref rid="B34" ref-type="bibr">34</xref>], curcumin (IC<sub>50</sub> of 13.3 &#x000b1; 0.7&#x02009;<italic>&#x003bc;</italic>g/mL) [<xref rid="B36" ref-type="bibr">36</xref>], and quercetin (IC<sub>50</sub> of 18.6 &#x000b1; 0.8&#x02009;<italic>&#x003bc;</italic>g/mL) [<xref rid="B36" ref-type="bibr">36</xref>]. This result is valid for lipases tested (<xref rid="tab6" ref-type="table">Table 6</xref>).</p><p>The group IB phospholipase A<sub>2</sub> gene has previously been associated to human obesity and diabetes [<xref rid="B38" ref-type="bibr">38</xref>] because of the catalytic activity of its encoded enzyme, which liberates lysophospholipids. The absorption of these lysophospholipids promotes insulin resistance and tissue lipid deposition [<xref rid="B39" ref-type="bibr">39</xref>]. It has also been reported that group IB phospholipase A<sub>2</sub> deficiency protects against high-carbohydrate diet-induced hyperlipidemia and obesity in mice [<xref rid="B40" ref-type="bibr">40</xref>]. Remarkably, the secretion of this enzyme predominantly during the gastrointestinal digestion suggests that oral administration of inhibitors may be a viable option for a potential therapy to suppress obesity and diabetes [<xref rid="B41" ref-type="bibr">41</xref>], hence the importance to discover new natural group IB PLA<sub>2</sub> inhibitors.</p><p>Data of the present study clearly indicate the efficiency of <italic>E. cyparissias</italic> extracts even at low concentrations to inhibit digestive phospholipase activities (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref rid="tab6" ref-type="table">Table 6</xref>), such as the case of lipase (<xref ref-type="fig" rid="fig1">Figure 1</xref>), which may confirm their potential use as a natural drug against obesity and diabetes.</p><p>Metabolic syndrome is one of the greatest threats to global health, especially because it increases the probability of developing cardiovascular diseases and type 2 diabetes, and includes conditions such as obesity, atherosclerosis, and hypertension, or a combination of these metabolic abnormalities [<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>]. People with syndrome should consume limited quantities of carbohydrates to maintain a balanced metabolism, which makes the inhibition of dietary carbohydrate digestion a logical target for pharmacological intervention, to reduce energy intake through gastrointestinal mechanisms. One of the effective solutions is to delay the glucose absorption through inhibition of key carbohydrate producing digestive enzymes. The major source of carbohydrates in the diet comes from starch, which is firstly hydrolyzed in the mouth by salivary amylase and thereafter by pancreatic <italic>&#x003b1;</italic>-amylase, producing disaccharides, which will be broken down to glucose by <italic>&#x003b2;</italic>-glucosidase in the intestine. Another biocatalyst, which is not considered a digestive enzyme but plays an important role in various forms of vascular injuries, is XO. It has previously been reported that the inhibition of the enzyme activity may exert beneficial effects on impaired vascular function associated or not with hypercholesterolemia and diabetes [<xref rid="B44" ref-type="bibr">44</xref>]. Thus, our purpose is to find a new natural, plant-based drug that could at the same time block XO activity and retard glucose absorption through the inhibition of carbohydrate hydrolyzing enzymes such as <italic>&#x003b1;</italic>-amylase and <italic>&#x003b2;</italic>-glucosidase to prevent metabolic syndrome.</p><p>As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, the inhibitory effect of ethanolic extract is found to be ~2 to 3 times higher than that obtained with aqueous extract which could be related to elevated phenolic and flavonoids content of ethanolic fractions of <italic>E. cyparissias</italic> that inhibit enzyme activities more specifically compared to aqueous extract, as previously described in the literature [<xref rid="B45" ref-type="bibr">45</xref>]. Furthermore, such as the case of digestive lipolytic enzymes (lipases and phospholipases, <xref rid="tab6" ref-type="table">Table 6</xref>), the inhibitory effect of the two extracts was more pronounced than those obtained with positive controls, which were acarbose for <italic>&#x003b1;</italic>-amylase and <italic>&#x003b2;</italic>-glucosidase and allopurinol for XO.</p><p>Unlike with lipids and carbohydrates, the benefits of inhibiting protein digestion are not clear-cut even though it may reduce calorie intake because of the suppression of digestive proteolytic activities during gastrointestinal transit. Digestion of proteins is catalyzed by a synergistic action of different digestive proteases which are secreted in the stomach (like endoproteinases), but mostly in the pancreas (trypsin, chymotrypsin, and elastase). Other proteases such as carboxypeptidase and aminopeptidase are also involved in protein digestion reactions [<xref rid="B46" ref-type="bibr">46</xref>].</p><p>In this study, we have selected the two pancreatic digestive proteases trypsin and chymotrypsin to observe their behavior in the presence of different concentrations of ethanolic and aqueous extracts of <italic>E. cyparissias</italic> (Figures <xref ref-type="fig" rid="fig4">4(a)</xref> and <xref ref-type="fig" rid="fig4">4(b)</xref>). The inhibitory effect of the two extracts was compared to that of the positive control with BBI [<xref rid="B47" ref-type="bibr">47</xref>]. These results were in line with those obtained previously by Huang et al. [<xref rid="B48" ref-type="bibr">48</xref>] who demonstrate that the phenolic compounds partially inhibit trypsin and a residual activity of trypsin was always maintained at 32%.</p><p>Antioxidant activities of both ethanolic and aqueous extracts were also investigated, and obtained results were compared to those of the BHT, which was used as a positive control <bold>(</bold><xref ref-type="fig" rid="fig5">Figure 5</xref><bold>)</bold>. One can notice from this figure that the two extracts had higher reducing power than that of BHT. The antioxidant activities of the two extracts could be related to the phenolic compounds produced by <italic>E. cyparissias</italic>, which is supported by several reports demonstrating a significant relationship between the phenolic compounds and the antioxidant activity [<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>].</p><p>In order to study whether ethanolic and aqueous extracts of <italic>E. cyparissias</italic> were able to produce inhibitory or lethal effect on human cell lines, the cytotoxicity of <italic>E. cyparissias</italic> extracts in MDA-MB-231, Lovo, and HCT-116 cells was evaluated (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Recorded data support our starting hypothesis of a viable use of <italic>E. cyparissias</italic> extracts as a therapeutic drug for metabolic syndrome or other related disease. <italic>In vivo</italic> and clinical studies are needed to support the results obtained in this study.</p></sec><sec id="sec5"><title>5. Conclusions</title><p>The results of this study indicate that E. <italic>cyparissias</italic> is a good source of inhibitors for various digestive enzymes (such as <italic>&#x003b1;</italic>-amylase and <italic>&#x003b2;</italic>-glucosidase, lipases, and phospholipases) and has considerable antioxidant properties. In addition, the ethanolic extract was found to present a higher inhibition activity when compared to the aqueous extract and all positive or commercial inhibitors used. Therefore, this new natural plant-based drug may be a promising alternative to prevent and treat metabolic syndrome.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group no. RG-1441-471.</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>The data used to support the findings of this study are available from the corresponding author upon request.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.</p></sec><sec><title>Authors' Contributions</title><p>All authors have read and agree to the published version of the manuscript. A.B.B. is responsible for the conceptualization and supervision. M.A., M.A., and A.B.B. conducted the experiment and curated the data. H.H. is assigned to writing, review, and editing.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saklayen</surname><given-names>M. G.</given-names></name></person-group><article-title>The global epidemic of the metabolic syndrome</article-title><source><italic toggle="yes">Current Hypertension Reports</italic></source><year>2018</year><volume>20</volume><issue>2</issue><fpage>p. 12</fpage><pub-id pub-id-type="doi">10.1007/s11906-018-0812z</pub-id><?supplied-pmid 29480368?><pub-id pub-id-type="pmid">29480368</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galeno</surname><given-names>D. M. L.</given-names></name><name><surname>Carvalho</surname><given-names>R. P.</given-names></name><name><surname>de Ara&#x000fa;jo Boleti</surname><given-names>A. P.</given-names></name><etal/></person-group><article-title>Extract from Eugenia <italic>punicifolia</italic> is an antioxidant and inhibits enzymes related to metabolic syndrome</article-title><source><italic toggle="yes">Applied Biochemistry and Biotechnology</italic></source><year>2014</year><volume>172</volume><issue>1</issue><fpage>311</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1007/s12010-013-0520-8</pub-id><pub-id pub-id-type="other">2-s2.0-84894418355</pub-id><pub-id pub-id-type="pmid">24078187</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornier</surname><given-names>M.-A.</given-names></name><name><surname>Dabelea</surname><given-names>D.</given-names></name><name><surname>Hernandez</surname><given-names>T. L.</given-names></name><etal/></person-group><article-title>The metabolic syndrome</article-title><source><italic toggle="yes">Endocrine Reviews</italic></source><year>2008</year><volume>29</volume><issue>7</issue><fpage>777</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1210/er.2008-0024</pub-id><pub-id pub-id-type="other">2-s2.0-57349096045</pub-id><?supplied-pmid 18971485?><pub-id pub-id-type="pmid">18971485</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grundy</surname><given-names>S. M.</given-names></name></person-group><article-title>Metabolic syndrome pandemic</article-title><source><italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic></source><year>2008</year><volume>28</volume><issue>4</issue><fpage>629</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.107.151092</pub-id><pub-id pub-id-type="other">2-s2.0-42249093870</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadhurst</surname><given-names>C. L.</given-names></name><name><surname>Polansky</surname><given-names>M. M.</given-names></name><name><surname>Anderson</surname><given-names>R. A.</given-names></name></person-group><article-title>Insulin-like biological activity of culinary and medicinal plant aqueous extracts <italic>in vitro</italic></article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2000</year><volume>48</volume><issue>3</issue><fpage>849</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1021/jf9904517</pub-id><pub-id pub-id-type="other">2-s2.0-0034117424</pub-id><?supplied-pmid 10725162?><pub-id pub-id-type="pmid">10725162</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okla</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Koehler</surname><given-names>K.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name></person-group><article-title>Dietary factors promoting brown and beige fat development and thermogenesis</article-title><source><italic toggle="yes">Advances in Nutrition: An International Review Journal</italic></source><year>2017</year><volume>8</volume><issue>3</issue><fpage>473</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.3945/an.116.014332</pub-id><pub-id pub-id-type="other">2-s2.0-85020225031</pub-id><?supplied-pmid 28507012?><pub-id pub-id-type="pmid">28507012</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birari</surname><given-names>R. B.</given-names></name><name><surname>Bhutani</surname><given-names>K. K.</given-names></name></person-group><article-title>Pancreatic lipase inhibitors from natural sources: unexplored potential</article-title><source><italic toggle="yes">Drug Discovery Today</italic></source><year>2007</year><volume>12</volume><issue>19-20</issue><fpage>879</fpage><lpage>889</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2007.07.024</pub-id><pub-id pub-id-type="other">2-s2.0-35148885200</pub-id><?supplied-pmid 17933690?><pub-id pub-id-type="pmid">17933690</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDougall</surname><given-names>G. J.</given-names></name><name><surname>Stewart</surname><given-names>D.</given-names></name></person-group><article-title>The inhibitory effects of berry polyphenols on digestive enzymes</article-title><source><italic toggle="yes">BioFactors</italic></source><year>2005</year><volume>23</volume><issue>4</issue><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1002/biof.5520230403</pub-id><pub-id pub-id-type="other">2-s2.0-33144478510</pub-id><?supplied-pmid 16498205?><pub-id pub-id-type="pmid">16498205</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>T.</given-names></name><name><surname>Ueda</surname><given-names>T.</given-names></name><name><surname>Oki</surname><given-names>T.</given-names></name><name><surname>Sugita</surname><given-names>K.</given-names></name><name><surname>Terahara</surname><given-names>N.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name></person-group><article-title>
<italic>&#x003b1;</italic>-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2001</year><volume>49</volume><issue>4</issue><fpage>1948</fpage><lpage>1951</lpage><pub-id pub-id-type="doi">10.1021/jf001251u</pub-id><pub-id pub-id-type="other">2-s2.0-0034861322</pub-id><?supplied-pmid 11308351?><pub-id pub-id-type="pmid">11308351</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Kashket</surname><given-names>S.</given-names></name></person-group><article-title>Inhibition of salivary amylase by black and green teas and their effects on the intra-oral hydrolysis of starch</article-title><source><italic toggle="yes">Caries Research</italic></source><year>1997</year><volume>32</volume><fpage>233</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1159/000016458</pub-id><pub-id pub-id-type="other">2-s2.0-0031627432</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toeller</surname><given-names>M. R.</given-names></name></person-group><article-title>
<italic>&#x003b1;</italic>-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects</article-title><source><italic toggle="yes">European Journal of Clinical Investigation</italic></source><year>1994</year><volume>24</volume><issue>S3</issue><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2362.1994.tb02253.x</pub-id><pub-id pub-id-type="other">2-s2.0-0028147171</pub-id><pub-id pub-id-type="pmid">8001625</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>J. L.</given-names></name><name><surname>Cryer</surname><given-names>B.</given-names></name></person-group><article-title>Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies</article-title><source><italic toggle="yes">Drug, Healthcare and Patient Safety</italic></source><year>2015</year><volume>7</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.2147/dhps.s71976</pub-id><pub-id pub-id-type="other">2-s2.0-84921830092</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bani</surname><given-names>S.</given-names></name><name><surname>Kaul</surname><given-names>A.</given-names></name><name><surname>Jaggi</surname><given-names>B. S.</given-names></name><name><surname>Suri</surname><given-names>K. A.</given-names></name><name><surname>Suri</surname><given-names>O. P.</given-names></name><name><surname>Sharma</surname><given-names>O. P.</given-names></name></person-group><article-title>Anti-inflammatory activity of the hydrosoluble fraction of <italic>Euphorbia royleana</italic> latex</article-title><source><italic toggle="yes">Fitoterapia</italic></source><year>2000</year><volume>71</volume><issue>6</issue><fpage>655</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(00)00225-2</pub-id><pub-id pub-id-type="other">2-s2.0-0033765519</pub-id><pub-id pub-id-type="pmid">11077172</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanhers</surname><given-names>M. C.</given-names></name><name><surname>Fleurentin</surname><given-names>J.</given-names></name><name><surname>Dorfman</surname><given-names>P.</given-names></name><name><surname>Mortier</surname><given-names>F.</given-names></name><name><surname>Pelt</surname><given-names>J. M.</given-names></name></person-group><article-title>Analgesic, antipyretic and anti-inflammatory properties <italic>of Euphorbia hirta</italic></article-title><source><italic toggle="yes">Planta Medica</italic></source><year>1991</year><volume>57</volume><issue>3</issue><fpage>225</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1055/s-2006-960079</pub-id><pub-id pub-id-type="pmid">1896520</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falodun</surname><given-names>A.</given-names></name><name><surname>Okunrobo</surname><given-names>L. O.</given-names></name><name><surname>Uzoamaka</surname><given-names>N.</given-names></name></person-group><article-title>Phytochemical screening and anti-inflammatory evaluation of methanolic and aqueous extracts of <italic>Euphorbia heterophylla</italic> Linn (<italic>Euphorbiaceae</italic>)</article-title><source><italic toggle="yes">African Journal of Biotechnology</italic></source><year>2006</year><volume>5</volume><issue>6</issue><fpage>529</fpage><lpage>531</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amani</surname><given-names>A. S.</given-names></name><name><surname>Alothman</surname><given-names>M. R.</given-names></name><name><surname>Zain</surname><given-names>Y. M.</given-names></name><name><surname>Alqasoumi</surname><given-names>S. I.</given-names></name><name><surname>Alothman</surname><given-names>E. A.</given-names></name></person-group><article-title>Quantitative and qualitative analysis for standardization of <italic>Euphorbia cuneate</italic> Vahl</article-title><source><italic toggle="yes">Saudi Pharmaceutical Journal</italic></source><year>2017</year><volume>25</volume><issue>8</issue><fpage>1175</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2017.08.001</pub-id><pub-id pub-id-type="other">2-s2.0-85027524372</pub-id><pub-id pub-id-type="pmid">30166906</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacha</surname><given-names>A. B.</given-names></name><name><surname>Jemel</surname><given-names>I.</given-names></name><name><surname>Bahat</surname><given-names>R. S.</given-names></name><name><surname>Alonazi</surname><given-names>M. A.</given-names></name></person-group><article-title>Inhibitory effects of various solvent extracts from Rhamnus frangula leaves on some inflammatory and metabolic enzymes</article-title><source><italic toggle="yes">Cellular and Molecular Biology</italic></source><year>2018</year><volume>64</volume><issue>13</issue><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.14715/cmb/2018.64.13.11</pub-id><pub-id pub-id-type="other">2-s2.0-85056423861</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacha</surname><given-names>A. B.</given-names></name><name><surname>Gargouri</surname><given-names>Y.</given-names></name><name><surname>Bezzine</surname><given-names>S.</given-names></name><name><surname>Mejdoub</surname><given-names>H.</given-names></name></person-group><article-title>Purification and biochemical characterization of phospholipase A2 from dromedary pancreas</article-title><source><italic toggle="yes">Biochimica et Biophysica Acta</italic></source><year>2006</year><volume>1760</volume><issue>8</issue><fpage>1202</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2006.03.014</pub-id><pub-id pub-id-type="other">2-s2.0-33745479091</pub-id><?supplied-pmid 16733083?><pub-id pub-id-type="pmid">16733083</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacha</surname><given-names>A. B.</given-names></name><name><surname>Karray</surname><given-names>A.</given-names></name><name><surname>Bouchaala</surname><given-names>E.</given-names></name><name><surname>Gargouri</surname><given-names>Y.</given-names></name><name><surname>Ali</surname><given-names>Y. B.</given-names></name></person-group><article-title>Purification and biochemical characterization of pancreatic phospholipase A2 from the common stingray Dasyatis pastinaca</article-title><source><italic toggle="yes">Lipids in Health and Disease</italic></source><year>2011</year><volume>10</volume><issue>1</issue><fpage>p. 32</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-32</pub-id><pub-id pub-id-type="other">2-s2.0-79952450724</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Haas</surname><given-names>G. H.</given-names></name><name><surname>Postema</surname><given-names>N. M.</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>W.</given-names></name><name><surname>van Deenen</surname><given-names>L. L. M.</given-names></name></person-group><article-title>Purification and properties of an anionic zymogen of phospholipase a from porcine pancreas</article-title><source><italic toggle="yes">Biochimica et Biophysica Acta (BBA) - Enzymology</italic></source><year>1968</year><volume>159</volume><issue>1</issue><fpage>118</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/0005-2744(68)90249-0</pub-id><pub-id pub-id-type="other">2-s2.0-0014428368</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verger</surname><given-names>R.</given-names></name><name><surname>De Haas</surname><given-names>G. H.</given-names></name><name><surname>Sarda</surname><given-names>L.</given-names></name><name><surname>Desnuelle</surname><given-names>P.</given-names></name></person-group><article-title>Purification from porcine pancreas of two molecular species with lipase activity</article-title><source><italic toggle="yes">Biochimica et Biophysica Acta (BBA) - Protein Structure</italic></source><year>1969</year><volume>188</volume><issue>2</issue><fpage>272</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/0005-2795(69)90075-0</pub-id><pub-id pub-id-type="other">2-s2.0-0014458576</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mejdoub</surname><given-names>H.</given-names></name><name><surname>Reinbolt</surname><given-names>J.</given-names></name><name><surname>Gargouri</surname><given-names>Y.</given-names></name></person-group><article-title>Dromedary pancreatic lipase: purification and structural properties</article-title><source><italic toggle="yes">Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism</italic></source><year>1994</year><volume>1213</volume><issue>2</issue><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(94)90017-5</pub-id><pub-id pub-id-type="other">2-s2.0-0028359791</pub-id><?supplied-pmid 8025121?><pub-id pub-id-type="pmid">8025121</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fendri</surname><given-names>A.</given-names></name><name><surname>Frikha</surname><given-names>F.</given-names></name><name><surname>Mosbah</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Biochemical characterization, cloning, and molecular modelling of chicken pancreatic lipase</article-title><source><italic toggle="yes">Archives of Biochemistry and Biophysics</italic></source><year>2006</year><volume>451</volume><issue>2</issue><fpage>149</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2006.04.018</pub-id><pub-id pub-id-type="other">2-s2.0-33745713804</pub-id><?supplied-pmid 16780787?><pub-id pub-id-type="pmid">16780787</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ara&#x000fa;jo</surname><given-names>A. L.</given-names></name><name><surname>Radvanyi</surname><given-names>F.</given-names></name></person-group><article-title>Determination of phospholipase A2 activity by a colorimetric assay using a pH indicator</article-title><source><italic toggle="yes">Toxicon</italic></source><year>1987</year><volume>25</volume><issue>11</issue><fpage>1181</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(87)90136-X</pub-id><pub-id pub-id-type="other">2-s2.0-0023516712</pub-id><pub-id pub-id-type="pmid">3433293</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>R.</given-names></name><name><surname>Asmawi</surname><given-names>M. Z.</given-names></name><name><surname>Sadikun</surname><given-names>A.</given-names></name></person-group><article-title>In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide</article-title><source><italic toggle="yes">Acta Biochimica Polonica</italic></source><year>2008</year><volume>55</volume><issue>2</issue><fpage>391</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.18388/abp.2008_3087</pub-id><?supplied-pmid 18511986?><pub-id pub-id-type="pmid">18511986</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondet</surname><given-names>V.</given-names></name><name><surname>Brand-Williams</surname><given-names>W.</given-names></name><name><surname>Berset</surname><given-names>C.</given-names></name></person-group><article-title>Kinetics and mechanisms of antioxidant activity using the DPPH.free radical method</article-title><source><italic toggle="yes">Lebensmittel-Wissenschaft - Food Science and Technology</italic></source><year>1997</year><volume>30</volume><issue>6</issue><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1006/fstl.1997.0240</pub-id><pub-id pub-id-type="other">2-s2.0-0031232088</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunitz</surname><given-names>M.</given-names></name></person-group><article-title>Crystalline soybean trypsin inhibitor</article-title><source><italic toggle="yes">The Journal of General Physiology</italic></source><year>1947</year><volume>30</volume><issue>4</issue><fpage>291</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1085/jgp.30.4.291</pub-id><?supplied-pmid 19873496?><pub-id pub-id-type="pmid">19873496</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bersuder</surname><given-names>P.</given-names></name><name><surname>Hole</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>G.</given-names></name></person-group><article-title>Antioxidants from a heated histidine-glucose model system. I: investigation of the antioxidant role of histidine and isolation of antioxidants by high-performance liquid chromatography</article-title><source><italic toggle="yes">Journal of the American Oil Chemists' Society</italic></source><year>1998</year><volume>75</volume><issue>2</issue><fpage>181</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1007/s11746-998-0030-y</pub-id><pub-id pub-id-type="other">2-s2.0-0031999603</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyaizu</surname><given-names>M.</given-names></name></person-group><article-title>Studies on products of browning reaction. Antioxidative activities of products of browning reaction prepared from glucosamine</article-title><source><italic toggle="yes">The Japanese Journal of Nutrition and Dietetics</italic></source><year>1986</year><volume>44</volume><issue>6</issue><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.5264/eiyogakuzashi.44.307</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="other"><collab>US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute</collab><source><italic toggle="yes">Why Obesity Is a Health Problem</italic></source><year>2013</year><comment><ext-link ext-link-type="uri" xlink:href="https://www.nhlbi.nih.gov/health/educational/wecan/healthy-weight-basics/obesity.htm">https://www.nhlbi.nih.gov/health/educational/wecan/healthy-weight-basics/obesity.htm</ext-link></comment></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballinger</surname><given-names>A.</given-names></name><name><surname>Peikin</surname><given-names>S. R.</given-names></name></person-group><article-title>Orlistat: its current status as an anti-obesity drug</article-title><source><italic toggle="yes">European Journal of Pharmacology</italic></source><year>2002</year><volume>440</volume><issue>2&#x02013;3</issue><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/S0014-2999(02)01422-X</pub-id><pub-id pub-id-type="other">2-s2.0-0037066585</pub-id><?supplied-pmid 12007529?><pub-id pub-id-type="pmid">12007529</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Burn</surname><given-names>P.</given-names></name></person-group><article-title>Lipid metabolic enzymes: emerging drug targets for the treatment of obesity</article-title><source><italic toggle="yes">Nature Reviews Drug Discovery</italic></source><year>2004</year><volume>3</volume><issue>8</issue><fpage>695</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1038/nrd1469</pub-id><pub-id pub-id-type="other">2-s2.0-4344598315</pub-id><pub-id pub-id-type="pmid">15286736</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unuofin</surname><given-names>J. O.</given-names></name><name><surname>Otunola</surname><given-names>G. A.</given-names></name><name><surname>Afolayan</surname><given-names>A. J.</given-names></name></person-group><article-title>In vitro <italic>&#x003b1;</italic>-amylase, <italic>&#x003b1;</italic>-glucosidase, lipase inhibitory and cytotoxic activities of tuber extracts of <italic>Kedrostis africana</italic> (L.) Cogn</article-title><source><italic toggle="yes">Heliyon</italic></source><year>2018</year><volume>4</volume><issue>9, article e00810</issue><pub-id pub-id-type="doi">10.1016/j.heliyon.2018.e00810</pub-id><pub-id pub-id-type="other">2-s2.0-85053819897</pub-id><?supplied-pmid 30294692?><pub-id pub-id-type="pmid">30294692</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaradat</surname><given-names>N.</given-names></name><name><surname>Zaid</surname><given-names>A.</given-names></name><name><surname>Hussein</surname><given-names>F.</given-names></name><name><surname>Zaqzouq</surname><given-names>M.</given-names></name><name><surname>Aljammal</surname><given-names>H.</given-names></name><name><surname>Ayesh</surname><given-names>O.</given-names></name></person-group><article-title>Anti-lipase potential of the organic and aqueous extracts of ten traditional edible and medicinal plants in Palestine; a comparison study with orlistat</article-title><source><italic toggle="yes">Medicines</italic></source><year>2017</year><volume>4</volume><issue>4</issue><fpage>p. 89</fpage><pub-id pub-id-type="doi">10.3390/medicines4040089</pub-id><?supplied-pmid 29292744?><pub-id pub-id-type="pmid">29292744</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>S.-L.</given-names></name><name><surname>Mah</surname><given-names>S.-H.</given-names></name><name><surname>Lai</surname><given-names>H.-Y.</given-names></name></person-group><article-title>Porcine Pancreatic Lipase Inhibitory Agent Isolated from Medicinal Herb and Inhibition Kinetics of Extracts from <italic>Eleusine indica</italic> (L.) Gaertner</article-title><source><italic toggle="yes">Journal of Pharmaceutics</italic></source><year>2016</year><volume>2016</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1155/2016/8764274</pub-id><pub-id pub-id-type="publisher-id">8764274</pub-id><?supplied-pmid 27872792?><pub-id pub-id-type="pmid">27872792</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chompoo</surname><given-names>J.</given-names></name><name><surname>Upadhyay</surname><given-names>A.</given-names></name><name><surname>Gima</surname><given-names>S.</given-names></name><name><surname>Fukuta</surname><given-names>M.</given-names></name><name><surname>Tawata</surname><given-names>S.</given-names></name></person-group><article-title>Antiatherogenic properties of acetone extract of <italic>Alpinia zerumbet</italic> seeds</article-title><source><italic toggle="yes">Molecules</italic></source><year>2012</year><volume>17</volume><issue>6</issue><fpage>6237</fpage><lpage>6248</lpage><pub-id pub-id-type="doi">10.3390/molecules17066237</pub-id><pub-id pub-id-type="other">2-s2.0-84862979235</pub-id><?supplied-pmid 22634836?><pub-id pub-id-type="pmid">22634836</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slanc</surname><given-names>P.</given-names></name><name><surname>Doljak</surname><given-names>B.</given-names></name><name><surname>Kreft</surname><given-names>S.</given-names></name><name><surname>Lunder</surname><given-names>M.</given-names></name><name><surname>Janes</surname><given-names>D.</given-names></name><name><surname>Strukelj</surname><given-names>B.</given-names></name></person-group><article-title>Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>2009</year><volume>23</volume><issue>6</issue><fpage>874</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1002/ptr.2718</pub-id><pub-id pub-id-type="other">2-s2.0-67149093755</pub-id><?supplied-pmid 19107742?><pub-id pub-id-type="pmid">19107742</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>S. G.</given-names></name><name><surname>Adam</surname><given-names>G.</given-names></name><name><surname>Langdown</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort</article-title><source><italic toggle="yes">European Journal of Human Genetics</italic></source><year>2006</year><volume>14</volume><issue>3</issue><fpage>340</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1038/sj.ejhg.5201551</pub-id><pub-id pub-id-type="other">2-s2.0-33645152985</pub-id><?supplied-pmid 16391564?><pub-id pub-id-type="pmid">16391564</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labont&#x000e9;</surname><given-names>E. D.</given-names></name><name><surname>Kirby</surname><given-names>R. J.</given-names></name><name><surname>Schildmeyer</surname><given-names>N. M.</given-names></name><name><surname>Cannon</surname><given-names>A. M.</given-names></name><name><surname>Huggins</surname><given-names>K. W.</given-names></name><name><surname>Hui</surname><given-names>D. Y.</given-names></name></person-group><article-title>Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia</article-title><source><italic toggle="yes">Diabetes</italic></source><year>2006</year><volume>55</volume><issue>4</issue><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.2337/diabetes.55.04.06.db05-1286</pub-id><pub-id pub-id-type="other">2-s2.0-33745309628</pub-id><?supplied-pmid 16567514?><pub-id pub-id-type="pmid">16567514</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huggins</surname><given-names>K. W.</given-names></name><name><surname>Boileau</surname><given-names>A. C.</given-names></name><name><surname>Hui</surname><given-names>D. Y.</given-names></name></person-group><article-title>Protection against diet-induced obesity and obesity- related insulin resistance in group 1B PLA2-deficient mice</article-title><source><italic toggle="yes">American Journal of Physiology</italic></source><year>2002</year><volume>283</volume><issue>5</issue><fpage>E994</fpage><lpage>E1001</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00110.2002</pub-id><?supplied-pmid 12376327?><pub-id pub-id-type="pmid">12376327</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollie</surname><given-names>N. I.</given-names></name><name><surname>Hui</surname><given-names>D. Y.</given-names></name></person-group><article-title>Group 1B phospholipase A2deficiency protects against diet-induced hyperlipidemia in mice</article-title><source><italic toggle="yes">Journal of Lipid Research</italic></source><year>2011</year><volume>52</volume><issue>11</issue><fpage>2005</fpage><lpage>2011</lpage><pub-id pub-id-type="doi">10.1194/jlr.M019463</pub-id><pub-id pub-id-type="other">2-s2.0-80054111473</pub-id><?supplied-pmid 21908646?><pub-id pub-id-type="pmid">21908646</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>J.</given-names></name></person-group><article-title>A comprehensive review on metabolic syndrome</article-title><source><italic toggle="yes">Cardiology Research and Practice</italic></source><year>2014</year><volume>2014</volume><fpage>21</fpage><pub-id pub-id-type="publisher-id">943162</pub-id><pub-id pub-id-type="doi">10.1155/2014/943162</pub-id><pub-id pub-id-type="other">2-s2.0-84897522177</pub-id><?supplied-pmid 24711954?><pub-id pub-id-type="pmid">24711954</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanderley</surname><given-names>E. N.</given-names></name><name><surname>Ferreira</surname><given-names>V. A.</given-names></name></person-group><article-title>Obesity: a plural perspective</article-title><source><italic toggle="yes">Ci&#x000ea;ncia &#x00026; Sa&#x000fa;de Coletiva</italic></source><year>2010</year><volume>15</volume><issue>1</issue><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1590/S1413-81232010000100024</pub-id><?supplied-pmid 20169245?><pub-id pub-id-type="pmid">20169245</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>C. E.</given-names></name><name><surname>Hare</surname><given-names>J. M.</given-names></name></person-group><article-title>Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications</article-title><source><italic toggle="yes">The Journal of Physiology</italic></source><year>2004</year><volume>555</volume><issue>3</issue><fpage>589</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.055913</pub-id><pub-id pub-id-type="other">2-s2.0-1642484244</pub-id><?supplied-pmid 14694147?><pub-id pub-id-type="pmid">14694147</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisano</surname><given-names>M. B.</given-names></name><name><surname>Cosentino</surname><given-names>S.</given-names></name><name><surname>Viale</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Biological activities of aerial parts extracts of <italic>Euphorbia characias</italic></article-title><source><italic toggle="yes">Biomedical Research and Science</italic></source><year>2016</year><volume>2016, article 1538703</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1155/2016/1538703</pub-id><pub-id pub-id-type="other">2-s2.0-84973616615</pub-id><?supplied-pmid 27314007?><pub-id pub-id-type="pmid">27314007</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dangin</surname><given-names>M.</given-names></name><name><surname>Boirie</surname><given-names>Y.</given-names></name><name><surname>Guillet</surname><given-names>C.</given-names></name><name><surname>Beaufrere</surname><given-names>B.</given-names></name></person-group><article-title>Influence of the protein digestion rate on protein turnover in young and elderly subjects</article-title><source><italic toggle="yes">Journal of Nutrition</italic></source><year>2002</year><volume>132</volume><issue>10</issue><fpage>3228S</fpage><lpage>3233S</lpage><pub-id pub-id-type="doi">10.1093/jn/131.10.3228S</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birk</surname><given-names>Y.</given-names></name></person-group><article-title>The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans</article-title><source><italic toggle="yes">International Journal of Peptide and Protein Research</italic></source><year>1985</year><volume>25</volume><issue>2</issue><fpage>113</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3011.1985.tb02155.x</pub-id><pub-id pub-id-type="other">2-s2.0-0022017412</pub-id><?supplied-pmid 3886572?><pub-id pub-id-type="pmid">3886572</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Kwok</surname><given-names>K.-C.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name></person-group><article-title>Effects of tea polyphenols on the activities of soybean trypsin inhibitors and trypsin</article-title><source><italic toggle="yes">Journal of the Science of Food and Agriculture</italic></source><year>2004</year><volume>84</volume><issue>2</issue><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1002/jsfa.1610</pub-id><pub-id pub-id-type="other">2-s2.0-0842287839</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kammoun</surname><given-names>M.</given-names></name><name><surname>Miladi</surname><given-names>S.</given-names></name><name><surname>Ali</surname><given-names>Y. B.</given-names></name><name><surname>Damak</surname><given-names>M.</given-names></name><name><surname>Gargouri</surname><given-names>Y.</given-names></name><name><surname>Bezzine</surname><given-names>S.</given-names></name></person-group><article-title>In vitro study of the PLA2 inhibition and antioxidant activities of Aloe vera leaf skin extracts</article-title><source><italic toggle="yes">Lipids in Health and Disease</italic></source><year>2011</year><volume>10</volume><issue>1</issue><fpage>p. 30</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-30</pub-id><pub-id pub-id-type="other">2-s2.0-79751537250</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velioglu</surname><given-names>Y. S.</given-names></name><name><surname>Mazza</surname><given-names>G.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Oomah</surname><given-names>B. D.</given-names></name></person-group><article-title>Antioxidant activity and total phenolics in selected fruits, vegetables and grain products</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>1998</year><volume>46</volume><issue>10</issue><fpage>4113</fpage><lpage>4117</lpage><pub-id pub-id-type="doi">10.1021/jf9801973</pub-id><pub-id pub-id-type="other">2-s2.0-0000087915</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Inhibitory effect of ethanol (a) and aqueous (b) extracts of <italic>Euphorbia cyparissias</italic> and commercial drug orlistat (c) on the dromedary (DrPL), stingray (SPL), and porcine (PPL) lipase activities. The activities of these lipases were measured using the pH-stat technique on olive oil emulsion at optimal conditions for enzyme activity. Values represent the mean &#x000b1; SD of triplicate measurements.</p></caption><graphic xlink:href="OMCL2020-9835167.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Inhibitory effect of ethanol (a) and aqueous (b) extracts of <italic>Euphorbia cyparissias</italic> and oleanolic acid (c) on DrPLA<sub>2</sub>-IB, SPLA<sub>2</sub>-IB, and PPLA<sub>2</sub>-IB phospholipase activities. The activities of these enzymes were measured using the pH-stat technique on olive oil emulsion at optimal conditions for enzyme activity. Values represent the mean &#x000b1; SD of triplicate measurements.</p></caption><graphic xlink:href="OMCL2020-9835167.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Inhibitory effect of ethanol and aqueous extracts of <italic>Euphorbia cyparissias</italic> on <italic>&#x003b1;</italic>-amylase (a), <italic>&#x003b2;</italic>-glucosidase (b), and antixanthine oxidase (c) activities. Values represent the mean &#x000b1; SD of triplicate measurements.</p></caption><graphic xlink:href="OMCL2020-9835167.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Inhibitory effect of ethanol aqueous extracts of <italic>Euphorbia cyparissias</italic> on trypsin (a) and chymotrypsin (b) activities. Each value is the mean of triplicate measurements &#x000b1; SD.</p></caption><graphic xlink:href="OMCL2020-9835167.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Antioxidant activities of ethanol and aqueous extracts tested with two methods: scavenging activity (a) and DPPH radical and reducing power activities (b). For each method, butylated hydroxytoluene (BHT) was used as standard, under the same conditions. Each value is the mean of triplicate measurements &#x000b1; SD. <sup>&#x02217;</sup>IC<sub>50</sub> (mg/L): the concentration at which 50% of the activity is inhibited. <sup>&#x02217;</sup>EC50 (mg/L): the effective concentration at which the absorbance reaches 0.5.</p></caption><graphic xlink:href="OMCL2020-9835167.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Cytotoxic effect of ethanol (a) and aqueous (b) extracts upon MDA-MB-231, Lovo, and HCT-116 cell lines. Experiments were performed in triplicate, and the results are expressed as a relative percentage of the optical density (OD) values measured in the control (untreated cells) and in the ethanolic or aqueous extract-treated cells. Results are reported as the means &#x000b1; SD of triplicate measurements.</p></caption><graphic xlink:href="OMCL2020-9835167.006"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Comparison of the IC<sub>50</sub> values of the two extracts from <italic>Euphorbia cyparissias</italic> and orlistat measured using DrPL, SPL, and PPL.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="3" rowspan="1">IC<sub>50</sub> (<italic>&#x003bc;</italic>g/mL)</th></tr><tr><th align="center" rowspan="1" colspan="1">DrPL</th><th align="center" rowspan="1" colspan="1">SPL</th><th align="center" rowspan="1" colspan="1">PPL</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ethanolic extract</td><td align="center" rowspan="1" colspan="1">8.0 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">2.9 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">2.3 &#x000b1; 0.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Aqueous extract</td><td align="center" rowspan="1" colspan="1">23.1 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">21.0 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">27.2 &#x000b1; 2.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Orlistat</td><td align="center" rowspan="1" colspan="1">97.2 &#x000b1; 2.5</td><td align="center" rowspan="1" colspan="1">109.8 &#x000b1; 4.2</td><td align="center" rowspan="1" colspan="1">52.1 &#x000b1; 2.3</td></tr></tbody></table><table-wrap-foot><fn><p>IC<sub>50</sub> (mg/L): the concentration at which 50% of the activity is inhibited.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparison of the IC<sub>50</sub> values of the two extracts from <italic>Euphorbia cyparissias</italic> to commercial orlistat using DrPLA<sub>2</sub>-IB, SPLA<sub>2</sub>-IB, and PPLA<sub>2</sub>-IB phospholipases.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="3" rowspan="1">IC<sub>50</sub> (<italic>&#x003bc;</italic>g/mL)</th></tr><tr><th align="center" rowspan="1" colspan="1">DrPLA<sub>2</sub>-IB</th><th align="center" rowspan="1" colspan="1">SPLA<sub>2</sub>-IB</th><th align="center" rowspan="1" colspan="1">PPLA<sub>2</sub>-IB</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ethanolic extract</td><td align="center" rowspan="1" colspan="1">4.2 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">5.9 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">9.6 &#x000b1; 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Aqueous extract</td><td align="center" rowspan="1" colspan="1">9.8 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">18.1 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">20.7 &#x000b1; 0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Oleanolic acid</td><td align="center" rowspan="1" colspan="1">79.3 &#x000b1; 3.5</td><td align="center" rowspan="1" colspan="1">82.8 &#x000b1; 5.7</td><td align="center" rowspan="1" colspan="1">46.1 &#x000b1; 0.7</td></tr></tbody></table><table-wrap-foot><fn><p>IC<sub>50</sub> (mg/L): the concentration at which 50% of the activity is inhibited.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison of the IC<sub>50</sub> values of the two extracts from <italic>Euphorbia cyparissias</italic> to commercial acarbose and allopurinol using <italic>&#x003b1;</italic>-amylase, <italic>&#x003b2;</italic>-glucosidase, and anti-xanthine oxidase.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="3" rowspan="1">IC<sub>50</sub> (<italic>&#x003bc;</italic>g/mL)</th></tr><tr><th align="center" rowspan="1" colspan="1">
<italic>&#x003b1;</italic>-Amylase</th><th align="center" rowspan="1" colspan="1">
<italic>&#x003b2;</italic>-Glucosidase</th><th align="center" rowspan="1" colspan="1">
<italic>&#x003b1;</italic>-Xanthine oxidase</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ethanolic extract</td><td align="center" rowspan="1" colspan="1">98.8 &#x000b1; 8.6</td><td align="center" rowspan="1" colspan="1">8.1 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">7.2 &#x000b1; 0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Aqueous extract</td><td align="center" rowspan="1" colspan="1">168.9 &#x000b1; 5.5</td><td align="center" rowspan="1" colspan="1">23.5 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">12.9 &#x000b1; 0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Acarbose</td><td align="center" rowspan="1" colspan="1">204.1 &#x000b1; 3.5</td><td align="center" rowspan="1" colspan="1">26.2 &#x000b1; 2.5</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Allopurinol</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">11.8 &#x000b1; 0.4</td></tr></tbody></table><table-wrap-foot><fn><p>IC<sub>50</sub> (mg/L): the concentration at which 50% of the activity is inhibited.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Comparison of the IC<sub>50</sub> values of the two extracts from <italic>Euphorbia cyparissias</italic> to commercial acarbose and allopurinol.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="2" rowspan="1">IC<sub>50</sub> (<italic>&#x003bc;</italic>g/L)</th></tr><tr><th align="center" rowspan="1" colspan="1">Trypsin</th><th align="center" rowspan="1" colspan="1">Chymotrypsin</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ethanolic extract</td><td align="center" rowspan="1" colspan="1">84.1 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">77.5 &#x000b1; 1.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Aqueous extract</td><td align="center" rowspan="1" colspan="1">&#x0003e;100</td><td align="center" rowspan="1" colspan="1">&#x0003e;100</td></tr><tr><td align="left" rowspan="1" colspan="1">BBI</td><td align="center" rowspan="1" colspan="1">11.5 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">10.8 &#x000b1; 0.4</td></tr></tbody></table><table-wrap-foot><fn><p>IC<sub>50</sub> (mg/L): the concentration at which 50% of the activity is inhibited.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Inhibitory effect of ethanol aqueous extracts of <italic>Euphorbia cyparissias</italic> on density of MDA-MB-231, Lovo, and HCT-116 cells compared to untreated cells at a concentration of 100&#x02009;<italic>&#x003bc;</italic>g/L.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="2" rowspan="1">Cell viability (%)</th></tr><tr><th align="center" rowspan="1" colspan="1">Ethanolic extract</th><th align="center" rowspan="1" colspan="1">Aqueous extract</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MDA-MB-231</td><td align="center" rowspan="1" colspan="1">5.5 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">57.5 &#x000b1; 0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Lovo</td><td align="center" rowspan="1" colspan="1">10.0 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">77.0 &#x000b1; 2.8</td></tr><tr><td align="left" rowspan="1" colspan="1">HCT-116</td><td align="center" rowspan="1" colspan="1">20.5 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">71.0 &#x000b1; 2.8</td></tr></tbody></table></table-wrap><table-wrap id="tab6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Comparison of the average IC<sub>50</sub> of <italic>E. cyparissias</italic> extracts on the studied enzymes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="2" rowspan="1">Average IC<sub>50</sub> (<italic>&#x003bc;</italic>g/mL)</th></tr><tr><th align="center" rowspan="1" colspan="1">Ethanolic extract</th><th align="center" rowspan="1" colspan="1">Aqueous extract</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Lipases</td><td align="center" rowspan="1" colspan="1">4.4 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">23.7 &#x000b1; 1.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Phospholipases</td><td align="center" rowspan="1" colspan="1">6.5 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">16.2 &#x000b1; 0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>&#x003b1;</italic>-Amylase</td><td align="center" rowspan="1" colspan="1">98.8 &#x000b1; 8.6</td><td align="center" rowspan="1" colspan="1">168.9 &#x000b1; 5.5</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>&#x003b2;</italic>-Glucosidase</td><td align="center" rowspan="1" colspan="1">8.1 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">23.5 &#x000b1; 0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Xanthine oxidase</td><td align="center" rowspan="1" colspan="1">7.2 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">12.9 &#x000b1; 0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Proteases</td><td align="center" rowspan="1" colspan="1">80.8 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">&#x0003e;100</td></tr><tr><td align="left" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" rowspan="1" colspan="1">30 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">&#x0003e;100</td></tr></tbody></table><table-wrap-foot><fn><p>Grey highlighted values correspond to those of IC<sub>50</sub> (<italic>&#x003bc;</italic>g/mL) that exceed lethal concentration of 50% cell death in the cell lines used.</p></fn></table-wrap-foot></table-wrap></floats-group></article>